Aprogen Medicines Inc. (KRX:007460)

South Korea · Delayed Price · Currency is KRW

2,375.00

-125.00 (-5.00%)

Last updated: Jun 24, 2026, 12:14 PM KST

-75.90% (1Y)

Market Cap	52.60B -74.0%
Revenue (ttm)	127.54B -8.1%
Net Income	-73.27B
EPS	-3,635.93
Shares Out	21.04M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	167,468
Open	2,500.00
Previous Close	2,500.00
Day's Range	2,355.00 - 2,620.00
52-Week Range	2,375.00 - 14,070.00
Beta	0.06
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Aprogen Medicines

Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foam... [Read more]

Industry Conglomerates

Sector Industrials

Founded 2000

Employees 256

Stock Exchange Korea Stock Exchange

Ticker Symbol 007460

Full Company Profile

Financial Performance

In 2025, Aprogen Medicines's revenue was 117.97 billion, a decrease of -21.41% compared to the previous year's 150.11 billion. Losses were -70.20 billion, 20.9% more than in 2024.

Financial Statements